INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,923 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
KG
King Terri GayDirector
OVVOvintiv Inc.
Grant or award
A—
3 sh
Jun 30, 2026Jul 2, 2026
Page 595 of 1724
← PrevNext →
traded Jun 30, 2026
+2d
SEC Form 4

Evidence

9
JL
Jones Bryn LlywelynDirector
FEAM5E Advanced Materials, Inc.
Option exercise
M—
5,118 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

9
BE
Bonanni Mark EmilioEVP, CRO, Commercial
OUTOUTFRONT Media Inc.
Option exercise
M—
4,507 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

9
BJ
Brown Christopher (John)President, TTEC Digital
TTECTTEC Holdings, Inc.
Tax withholding
F$456
217 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

9
LC
Lynch Andrew CharlesEVP & Chief Financial Officer
STSensata Technologies Holding plc
Grant or award
A—
1,364 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

9
PJ
Petty JoshuaEVP & General Counsel
BAHBooz Allen Hamilton Holding Corp
Tax withholding
F$15K
244 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

9
BM
Bazar Gregory MatthewDirector
SNVWSANUWAVE Health, Inc.
Grant or award
A—
5,524 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

9
MG
Munroe GavinDirector
FFIVF5, INC.
Grant or award
A—
700 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

9
MD
Mumford Gregory J.D.Chief Financial Officer
CIFRCipher Digital Inc.
Option exercise
M—
17.1K sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

9
AL
Advani LoveenChief Financial Officer
BETRBetter Home & Finance Holding Co
Option exercise
M—
9,167 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

8
BB
Bawel David BenjaminSVP & CHIEF ACCOUNTING OFFICER
DGICADONEGAL GROUP INC
Other acquisition or disposition
J$8,256
515 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

7
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise · 10b5-1 plan
M$20K
2,438 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

6
FS
Finn Mark StevenDirector
BBSIBARRETT BUSINESS SERVICES INC
Option exercise
M—
2,344 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

5
NA
Novack Jeffrey AdamSecretary and General Counsel
CDNACareDx, Inc.
Tax withholding
F$29K
997 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

5
CJ
Cordella Richard James JRDirector
MVBFMVB FINANCIAL CORP
Grant or award
A—
2,652 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

5
OM
O'Hara David MarkDirector
CDZICADIZ INC
Grant or award
A$19K
4,464 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

5
DD
Doukeris Michel DDirector
ECLECOLAB INC.
Grant or award
A—
130 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

5
FF
Famularo Adam FrancisDirector
MVBFMVB FINANCIAL CORP
Grant or award
A—
2,652 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

5
LM
Liu Teyin MDirector
MUMICRON TECHNOLOGY INC
Grant or award
A—
27 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

5
NA
Narayanan ArunChief Executive Officer
STEMSTEM, INC.
Option exercise
M—
8,125 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

5
OM
O'Hara David MarkDirector
CDZICADIZ INC
Grant or award
A$13K
3,052 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

4
KZ
Katz ZacharyCLO and Head of Global Affairs
GRNDGrindr Inc.
Open-market sale · 10b5-1 plan
SELL$208K
12.8K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

4
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$290K
3,500 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

4
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$327K
3,900 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

2
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Grant or award
A—
842 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

2
FS
Finn Mark StevenDirector
BBSIBARRETT BUSINESS SERVICES INC
Option exercise
M—
2,344 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

2
FS
Finn Mark StevenDirector
BBSIBARRETT BUSINESS SERVICES INC
Grant or award
A—
2,782 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

0
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise · 10b5-1 plan
M—
2,437 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

0
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise · 10b5-1 plan
M—
2,438 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

0
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
83.3K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

0
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise · 10b5-1 plan
M$20K
2,437 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

0
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
14.6K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

0
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
83.3K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

0
SE
Schubach Sarah ElizabethChief Accounting Officer
DBXDROPBOX, INC.
Open-market sale · 10b5-1 plan
SELL$35K
1,305 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

0
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$152K
14.6K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

0
WG
Whalen Thomas GerardDirector
HCSGHEALTHCARE SERVICES GROUP INC
Grant or award · 10b5-1 plan
A$2,505
102 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

52
SX
Shen XiaojieDirector
PSNYPolestar Automotive Holding UK PLC
Open-market purchase
BUY$42K
2,436 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

47
BP
Bhalla Narinder PalChief Medical Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$99K
22.3K sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

47
VW
Vahland WinfriedDirector
PSNYPolestar Automotive Holding UK PLC
Open-market purchase
BUY$102K
6,000 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

45
TA
Tpg Gp A, Llc10% Owner
NANATPG Twin Brook Capital Income Fund
Open-market purchase
BUY$100.00M
3.97M sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence